Cavitation and Chemotherapy Effects on Cancer in Rats
Author Information
Author(s): F. Pratl, J.-Y. Chapelon, F.A. El Fadill, Y. Theiller, T. Ponchon, D. Cathignol
Primary Institution: INSERM U281, Lyon, France
Hypothesis
Cavitation can enhance the effects of chemotherapy in treating peritoneal carcinomatosis in rats.
Conclusion
Cavitation is cytotoxic in vivo and enhances the effects of chemotherapy drugs like FUra and CDDP in this animal model.
Supporting Evidence
- Cavitation alone did not significantly improve outcomes compared to controls.
- High doses of FUra combined with cavitation resulted in 40% long-term disease-free survival.
- Survival after low dose FUra combined with cavitation was comparable to high dose FUra alone.
Takeaway
Cavitation, which is like making tiny bubbles in the body, can help make cancer treatments work better in rats.
Methodology
Rats with induced peritoneal carcinomatosis were treated with cavitation and chemotherapy, and their survival and clinical outcomes were assessed.
Limitations
The study was conducted in rats, and the technique used for cavitation is not yet applicable to humans.
Participant Demographics
Male and female BD IX rats, aged 8 to 12 weeks, weighing 190 to 320 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website